MeSH term | MeSH ID | Detail |
---|---|---|
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Norethindrone
MeSH term | MeSH ID | Detail |
---|---|---|
Arteriosclerosis | D001161 | 86 associated lipids |
Body Weight | D001835 | 333 associated lipids |
Pancreatic Neoplasms | D010190 | 77 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Koskela-Niska V et al. | Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy - a nationwide study. | 2013 | Climacteric | pmid:22640598 |
Brosnan JF et al. | Norethisterone acetate alters coagulation gene expression in vitro in human cell culture. | 2013 | Thromb. Res. | pmid:22999413 |
Zhou J et al. | Medroxyprogesterone acetate-driven increase in breast cancer risk might be mediated via cross-talk with growth factors in the presence of progesterone receptor membrane component-1. | 2013 | Maturitas | pmid:23856385 |
Juvkam KH and Gudim HB | [Drug induced displacement of menstruation]. | 2013 | Tidsskr. Nor. Laegeforen. | pmid:23344601 |
Buccellato E et al. | Possible occurrence of paraesthesia in patients taking norethisterone: an analysis on the WHO Global Individual Case Reports database (VigiBase). | 2013 | Expert Opin Drug Saf | pmid:23701188 |
Manassiev N et al. | Effects of tibolone or continuous combined oestradiol/norethisterone acetate on glucose and insulin metabolism. | 2013 | Clin. Endocrinol. (Oxf) | pmid:22775481 |
Merviel P et al. | [Interest of selective progesterone receptor modulators in endometriosis]. | 2013 | Gynecol Obstet Fertil | pmid:23972920 |
Abdul-Hadi RA et al. | The effectiveness of community based distribution of injectable contraceptives using community health extension workers in Gombe State, Northern Nigeria. | 2013 | Afr J Reprod Health | pmid:24069754 |
LoRusso PM et al. | Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential. | 2013 | Cancer Chemother. Pharmacol. | pmid:23064958 |
Jonusiene G et al. | Sexual function, mood and menopause symptoms in Lithuanian postmenopausal women. | 2013 | Climacteric | pmid:22845491 |